Menu
Search
Home > Courses > Prevalence of Human Papillomavirus Infection & Efficacy of a Quadrivalent HPV Vaccine In Men

Prevalence of Human Papillomavirus Infection & Efficacy of a Quadrivalent HPV Vaccine In Men

Prevalence of Human Papillomavirus Infection & Efficacy of a Quadrivalent HPV Vaccine In Men
Sorry, this learning module is not available for mobile devices.
This video is available at the Physicians Research Network website.

Original Release Date: 10/20/2009
Review Date: 10/20/2009
Presenter
  • Stephen E. Goldstone, MD, FACS
    Assistant Clinical Professor of Surgery
    Mount Sinai School of Medicine
Learning Objectives / Desired Outcomes
At the completion of this educational activity, participants will:
  1. Understand the efficacy of a quadrivalent HPV vaccine in men.
  2. Understand the prevalence of HPV infection in young heterosexual men.
  3. Understand the prevalence of HPV infection in young men who have sex with men.
Presenter Bio
Stephen Goldstone, MD, FACS
Stephen E. Goldstone is an Assistant Clinical Professor of Surgery at The Icahn School of Medicine at Mount Sinai and has a surgical practice in New York City. Dr. Goldstone has spoken at conferences around the world and has done extensive research on human papillomavirus (HPV). His work has been published in many prestigious medical journals, and is currently involved in testing both prevention and treatment procedures for HPV. He is a past-president of the International Anal Neoplasia Society and a member of the AIDS Malignancy Consortium.
PRN Learning Modules